免責聲明 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | --- | --- | | 股票發行人現金股息公告 | | | 發行人名稱 | 阜豐集團有限公司 | | 股份代號 | 00546 | | 多櫃檯股份代號及貨幣 | 不適用 | | 相關股份代號及名稱 | 不適用 | | 公告標題 截至2025年6月30日止六個月之特別中期股息 | | | 公告日期 | 2025年8月28日 | | 公告狀態 | 新公告 | | 股息信息 | | | 股息類型 | 其他 | | 特別中期股息 | | | 股息性質 | 特別股息 | | 財政年末 | 2025年12月31日 | | 宣派股息的報告期末 | 2025年6月30日 | | 宣派股息 | 每 股 0.121 HKD | | 股東批准日期 | 不適用 | | 香港過戶登記處相關信息 | | | 派息金額及公司預設派發貨幣 | 每 股 0.121 HKD | | 匯率 | 1 HKD : 1 ...

EF001 EF001 其他信息 其他信息 不適用 發行人董事 於本公告日期，本公司的執行董事為李學純先生，李德衡先生及李廣玉先生；而本公司的獨立非執行董事為劉仲緯先生，張友明先 生及李銘女士。 第 2 頁 共 2 頁 v 1.1.1 免責聲明 | 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 | | --- | --- | | 股票發行人現金股息公告 | | | 發行人名稱 | 阜豐集團有限公司 | | 股份代號 | 00546 | | 多櫃檯股份代號及貨幣 | 不適用 | | 相關股份代號及名稱 | 不適用 | | 公告標題 | 截至2025年6月30日止六個月之中期股息 | | 公告日期 | 2025年8月28日 | | 公告狀態 | 新公告 | | 股息信息 | | | 股息類型 | 中期（半年期） | | 股息性質 | 普通股息 | | 財政年末 | 2025年12月31日 | | 宣派股息的報告期末 | 2025年6月30日 | | 宣 ...

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. 香港交易及結算所有限公司以及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性或完整性亦不發表任 何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Fufeng Group Limited 阜豐集團有限公司 (Incorpor ...

Overview - Tryptophan is an essential amino acid that cannot be synthesized by the human body and must be obtained through food [2][4] - The market demand for tryptophan has rapidly increased due to the development of the livestock industry and the "reduction of soybean meal substitution" policy [4][9] - In 2024, the demand for tryptophan in China is projected to reach 23,800 tons, with a market size of 1.309 billion yuan [4][9] Market Policy - The Chinese government has issued several policies to support the development of the amino acid industry, including the "14th Five-Year Plan" and various guidelines for the pharmaceutical and feed industries [4][5] Industry Chain - The upstream of the tryptophan industry includes suppliers of raw materials like corn and molasses, while the midstream involves the production of tryptophan, and the downstream encompasses applications in feed, pharmaceuticals, health products, and food [6][7] Current Development - The feed sector accounts for over 70% of the demand for tryptophan in China, with industrial feed production expected to reach 158.5 million tons in the first half of 2025, a year-on-year increase of 7.7% [9][10] - The increasing focus on health foods has led to a rise in the use of tryptophan as a nutritional supplement for improving sleep and emotional balance [4][9] Competitive Landscape - The market concentration of tryptophan has increased, with international companies like Ajinomoto and CJ Cheiljedang holding significant market shares, while domestic companies such as Ningxia Yipin Biotechnology and Anhui Huaheng Biological Technology are gaining ground through innovation and resource advantages [10][11] Key Players - Fujian Group is a major player in the tryptophan market, with projected revenues of 27.76 billion yuan and a gross profit of 5.057 billion yuan in 2024 [12] - Anhui Huaheng Biological Technology focuses on synthetic biology and expects revenues of 2.178 billion yuan in 2024, with amino acid products contributing 69.28% of total revenue [12][13] Future Trends - The production of tryptophan is primarily through microbial fermentation, with future advancements expected in genetic engineering to enhance production efficiency and product purity [14] - There is a growing emphasis on green production processes to reduce costs and environmental impact, aligning with stricter environmental regulations [14]

Key Points - As of August 22, 108 stocks reached their 52-week highs, with Yicheng Group (08365), Shanghai Xiaonan Guo (03666), and Cybernaut International Holdings (01020) leading the high rate at 32.77%, 31.11%, and 20.16% respectively [1] - The closing prices for the top three stocks were 1.580, 0.051, and 0.155 respectively, indicating significant upward movement in their stock prices [1] - Other notable stocks that reached new highs include VALA (02051) at 18.87% and CTR Holdings (01416) at 16.52% [1] 52-Week High Rankings - The top three stocks with the highest increase rates were Yicheng Group (08365) at 32.77%, Shanghai Xiaonan Guo (03666) at 31.11%, and Cybernaut International Holdings (01020) at 20.16% [1] - The closing prices for these stocks were significantly higher than their previous values, indicating strong market performance [1] - The overall trend shows a positive sentiment in the market with many stocks achieving new highs [1] Additional Stocks Reaching New Highs - VALA (02051) reached a high of 0.630, marking an 18.87% increase, while CTR Holdings (01416) closed at 0.134, a 16.52% increase [1] - Other stocks such as Huaxing Capital Holdings (01911) and Huahong Semiconductor (01347) also showed positive performance with increases of 9.11% and 8.85% respectively [1]

Core Viewpoint - The glutamic acid market in China is experiencing growth driven by increasing food consumption, with a projected demand of 262.36 million tons in 2023, but is expected to decline to 256.53 million tons in 2024 due to macroeconomic factors [1][11]. Industry Overview - Glutamic acid is a significant food additive, primarily used as a flavor enhancer in the food industry, with over 60% of its demand coming from this sector [9][11]. - The market size for glutamic acid reached 236.67 billion yuan in 2023, but is forecasted to decrease to 202.97 billion yuan in 2024 [1][11]. Supply Chain - The upstream supply chain includes suppliers of raw materials like corn and starch, as well as auxiliary materials and production equipment [6]. - The midstream involves the production of glutamic acid, while the downstream applications span food, feed, and pharmaceuticals [6]. Competitive Landscape - The glutamic acid market in China is characterized by an oligopolistic structure, with leading companies like Fujian Group, Meihua Biological Technology, and Yipin Biological dominating the market, holding over 80% of the market share [15][18]. - Fujian Group reported a total revenue of 27.76 billion yuan in 2024, with a gross profit of 5.057 billion yuan [18]. - Meihua Biological Technology achieved a total revenue of 25.07 billion yuan in 2024, with a significant portion coming from animal nutrition amino acids [20]. Development Trends - There is a growing consumer preference for high-purity and low-sodium glutamic acid products, with L-glutamic acid and polyglutamic acid expected to be key growth areas [22]. - The industry is moving towards sustainable production practices, focusing on reducing energy consumption and waste, and improving water recycling and resource recovery [22].

Core Viewpoint - The amino acid market in China is experiencing growth driven by downstream sectors such as feed, food processing, pharmaceuticals, and health products, with a projected demand of 575.08 million tons in 2023, but expected to decline to 561.52 million tons in 2024 due to macroeconomic factors [1][19]. Overview - Amino acids are essential components of proteins and are widely used in various industries, including feed, food, and pharmaceuticals [2][6]. - The classification of amino acids includes essential, semi-essential, and non-essential types, with specific applications based on their properties [3][4]. Market Demand and Trends - The demand for amino acids is projected to decrease in 2024, with the market size expected to drop to 60.862 billion yuan, where glutamic acid accounts for 33.35%, lysine for 32.79%, threonine for 10.11%, methionine for 13.73%, and tryptophan for 2.15% [1][19]. - There is a growing consumer preference for natural and healthy products, which is expected to boost the demand for green and environmentally friendly amino acids and derivatives [1][19]. Industry Development - The amino acid industry in China has evolved from extraction methods to microbial fermentation, significantly reducing production costs and increasing efficiency [6][7]. - The industry is witnessing consolidation, with larger companies acquiring smaller ones to enhance market share and competitiveness [7][8]. Market Policies - Recent policies in China support technological innovation and industrial upgrades in the amino acid sector, promoting the use of amino acids in feed to ensure supply safety [10][12]. Industry Chain - The upstream of the amino acid industry includes suppliers of raw materials like corn, soybeans, and wheat, while the downstream encompasses applications in feed, food processing, pharmaceuticals, and health products [13][15]. - The feed sector is the largest market for amino acids, accounting for over 60% of demand, with significant growth in industrial feed production [17][19]. Competitive Landscape - The amino acid market in China is concentrated among leading companies such as Meihua Biological Technology Group, Fujian Fufeng Group, and Zhejiang New Hope Liuhe, which dominate the market [21][25]. - Meihua Biological is the largest producer of lysine, while Fufeng Group leads in MSG production, indicating a competitive environment with significant market players [21][27]. Future Trends - There is an increasing demand for high-purity amino acids in pharmaceuticals and cosmetics, supported by national policies favoring green production methods [29][30].

Group 1 - The company, 阜丰集团 (00546.HK), announced that its board of directors will hold a meeting on August 28, 2025, to consider and approve various matters [1] - The meeting will include the review of the unaudited interim results for the company and its subsidiaries for the period ending June 30, 2025 [1] - The board will also consider the declaration of an interim dividend, if applicable [1]

承董事會命 阜豐集團有限公司 董事長 李學純 （於開曼群島註冊成立的有限公司） （股份代號：546） 董事會會議日期 阜 豐 集 團 有 限 公 司（「本公司」）董 事 會（「董事會」）謹 此 宣 佈，本 公 司 董 事 會 將 於 二 零 二 五 年 八 月 二 十 八 日（星 期 四）舉 行 會 議，籍 以 考 慮 及 批 准 之 事 項，其 中 包 括 本 公 司 及 其 附 屬 公 司 截 至 二 零 二 五 年 六 月 三 十 日 止 的 未 經 審 核 中 期 業 績， 以 及 考 慮 派 付 中 期 股 息（如 有）。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 Fufeng Group Limited 阜豐集團有限公司 香 港，二 零 二 五 年 八 月 十 八 日 於 本 公 告 日 期，本 公 司 的 執 行 董 事 為 李 學 純 先 生、李 德 衡 先 生 及 李 廣 ...

Summary of Key Points Core Viewpoint - The report highlights the top short-selling stocks in Hong Kong, indicating significant short-selling activity in companies like New World Development, Hong Kong Exchanges, and BYD, with notable short-selling ratios and amounts [1][2]. Short-Selling Ratios - New World Development (80016) has the highest short-selling ratio at 100.00% - Hong Kong Exchanges (80388) follows with a short-selling ratio of 94.27% - BYD (81211) has a short-selling ratio of 94.13% [1][2]. Short-Selling Amounts - Alibaba (09988) leads in short-selling amount with HKD 1.546 billion - Tencent (00700) has a short-selling amount of HKD 1.265 billion - Xiaomi (01810) follows with HKD 1.188 billion [1][2]. Deviation Values - Hong Kong Exchanges (80388) has the highest deviation value at 54.37% - New World Development (80016) has a deviation value of 41.90% - Alibaba (89988) shows a deviation value of 39.84% [1][2].